Journal article icon

Journal article

Global distribution and prevalence of hepatitis C virus genotypes.

Abstract:
Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations in genotype prevalence. This poses a challenge to the improved development of vaccines and pan-genotypic treatments, which require the consideration of global trends in HCV genotype prevalence. Here we provide the first comprehensive survey of these trends. To approximate national HCV genotype prevalence, studies published between 1989 and 2013 reporting HCV genotypes are reviewed and combined with overall HCV prevalence estimates from the Global Burden of Disease (GBD) project. We also generate regional and global genotype prevalence estimates, inferring data for countries lacking genotype information. We include 1,217 studies in our analysis, representing 117 countries and 90% of the global population. We calculate that HCV genotype 1 is the most prevalent worldwide, comprising 83.4 million cases (46.2% of all HCV cases), approximately one-third of which are in East Asia. Genotype 3 is the next most prevalent globally (54.3 million, 30.1%); genotypes 2, 4, and 6 are responsible for a total 22.8% of all cases; genotype 5 comprises the remaining <1%. While genotypes 1 and 3 dominate in most countries irrespective of economic status, the largest proportions of genotypes 4 and 5 are in lower-income countries. Conclusion: Although genotype 1 is most common worldwide, nongenotype 1 HCV cases—which are less well served by advances in vaccine and drug development—still comprise over half of all HCV cases. Relative genotype proportions are needed to inform healthcare models, which must be geographically tailored to specific countries or regions in order to improve access to new treatments. Genotype surveillance data are needed from many countries to improve estimates of unmet need.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1002/hep.27259

Authors

More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Zoology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Role:
Author


IDAMS consortium More from this funder
Funding agency for:
Messina, J
Grant:
EC 21803
National Institute for Health Research Biomedical Research Centre Programme More from this funder
Funding agency for:
Barnes, E
Oxford Martin School More from this funder
Funding agency for:
Barnes, E
Medical Research Council More from this funder
Funding agency for:
Barnes, E


Publisher:
Wiley
Journal:
Hepatology More from this journal
Volume:
61
Issue:
1
Pages:
77-87
Publication date:
2015-01-01
DOI:
EISSN:
1527-3350
ISSN:
0270-9139


Language:
English
Keywords:
Pubs id:
pubs:477701
UUID:
uuid:47056e21-f7b2-4370-ac01-71f86cd95d5d
Local pid:
pubs:477701
Source identifiers:
477701
Deposit date:
2014-08-11
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP